Risk factor
Meaningful price volatility
Profitability factor
Favourable analyst view
About
Shanghai General Healthy Information and Technology Co., Ltd. (SGHIT) delivers a range of advanced solutions to the healthcare sector in China. These encompass automated pharmaceutical logistics, cutting-edge information technology, and intelligent, mobile medical applications. Its core product portfolio features the "Smart Pharmacy Project," an integrated hardware and software system designed for intelligent medication management. Another key offering is the "Intelligent Static Distribution Center Project," a sophisticated system for the configuration and oversight of intravenous medications. Additionally, the "Intelligent Drug Consumables Management Project" provides specialized oversight for various pharmaceutical supplies, including controlled substances and high-value medical items. Established in 2014, SGHIT operates from its headquarters in Shanghai, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of 605186.SS is 155 and suggests 386% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i